Argus Health Systems Company Profile

13:43 EDT 21st September 2018 | BioPortfolio

News Articles [1020 Associated News Articles listed on BioPortfolio]

Cardinal Health (CAH) Stock Rating Upgraded by Argus

The firm presently has a $85.00 target price on the stock. Argus' target price indicates a potential upside of 38.71% from the company's current price.

Apple-Aktie: Erwartungen könnten übertroffen werden!

New York ( - Apple-Aktienanalyse von Analyst Jim Kelleher von Argus Research: Aktienanalyst Jim Kelleher vom Investmenthaus Argus Research empfiehlt die Aktien von Apple Inc. (IS...

Celgene-Aktie: Furcht vor größerer Volatilität!

New York ( - Celgene-Aktienanalyse von Analyst David Toung von Argus Research: David Toung, Aktienanalyst vom Investmenthaus Argus Research, empfiehlt im Rahmen einer Aktienanaly...

IBM Watson Health Finds Nation's Top-Performing Health Systems Deliver More Consistent Care ...

This year's study finds that of those health systems surveyed, the country's top-performing health systems are achieving better clinical and operational performance through more consistent Read mo...

Argus Radiology Announces Expansion of Their TeleRadiology Services into Georgia

Argus Radiology is a Joint Commission accredited, radiologist owned, TeleRadiology company offering a unique business model that assigns a limited number of Radiologists to each facility (usually 5-7)...

Report: Health systems share Apple Health Records feedback

Responses from health systems touched on genuine excitement for how Apple’s technology could improve the

Sentara Healthcare named one of the “Top 15 Health Systems”

Norfolk-based Sentara Healthcare has been named one of the nation’s "Top 15 Health Systems” by IBM Watson Health. The annual list spotlights high-performing U.S. health systems based on a scoreca...

Pharmas Turn to Oracle to Meet New Drug Safety Reporting Regulations in China

SHANGHAI, June 26, 2018 /PRNewswire/ -- Luoxin Biotechnology (Shanghai) Co., Ltd. ("Luoxin Bio") and Innovent Biologics, Inc. ("Innovent Bio") have sele...

PubMed Articles [4974 Associated PubMed Articles listed on BioPortfolio]

Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients after Argus II Implantation: an International Study.

To assess the retinal anatomy and array position in the Argus II Retinal Prosthesis recipients.

Clinical diagnostic suspicion: a key component to being a modern Argus in medicine!

Systems thinking and ethics in public health: a necessary and mutually beneficial partnership.

Systems thinking has emerged as a means of conceptualizing and addressing complex public health problems, thereby challenging more commonplace understanding of problems and corresponding solutions as ...

Health Systems in Latin America: The Search for Universal Health Coverage.

This paper discusses the health challenges faced by countries in Latin America. These challenges have two dimensions: those related to the health needs of populations and those related to the way in w...

Using Systems Thinking to Advance Global Health Engagement in Education and Practice.

The integration of global health into nursing practice within complex systems requires a strategic approach. The System-Level Awareness Model (SAM) can be used to guide the process of enhancing system...

Clinical Trials [4092 Associated Clinical Trials listed on BioPortfolio]

New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to includ...

Argus II Retinal Prosthesis System - Better Vision RP Study

The study is conducted to evaluate the safety and benefit of the Argus II System in a selected patient population with advanced Retinitis Pigmentosa who have a measurable central residual ...

Argus™ II Retinal Stimulation System Feasibility Protocol

The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with severe to profo...

Self-confidence Study in Patients With Argus II Artificial Retina

To evaluate whether the use of the Argus II retinal prosthesis improves the confidence and self-esteem of patients with advanced retinopathy pigmentosa

Argus II/ORCAM Device Study

This study is being done to determine if wearable text-to-speech (TTS) and visual pattern recognition (VPR) technology can be used to extend the capabilities of the Argus II to allow patie...

Companies [3440 Associated Companies listed on BioPortfolio]

Argus Health Systems, Inc.

Argus is the leading independent provider of health care information management services supporting commercial, Medicare Part D, and Medicaid through a fully transparent business model. Argus is a who...

Argus Dental Plan

Founded in 2007 by a Florida dentist, Argus Dental Plan provides dental benefits that offer value and quality to all members. Argus is licensed through the Florida Department of I...

Argus Health Systems

Argus Dental & Vision, Inc.

Founded in 2007 by a Florida dentist, Argus Dental & Vision provides dental and vision benefits that offer value and quality to members. Argus is licensed through the Florida Depa...

DST HealthCare Holdings, Inc.

DST HealthCare is the holding company for Argus Health Systems, Inc. and DST Health Solutions, LLC.

More Information about "Argus Health Systems" on BioPortfolio

We have published hundreds of Argus Health Systems news stories on BioPortfolio along with dozens of Argus Health Systems Clinical Trials and PubMed Articles about Argus Health Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Argus Health Systems Companies in our database. You can also find out about relevant Argus Health Systems Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record